15 research outputs found
An unexpected link between fatty acid synthase and cholesterol synthesis in proinflammatory macrophage activation
Different immune activation states require distinct metabolic features and activities in immune cells. For instance, inhibition of fatty acid synthase (FASN), which catalyzes the synthesis of long-chain fatty acids, prevents the proinflammatory response in macrophages; however, the precise role of this enzyme in this response remains poorly defined. Consistent with previous studies, we found here that FASN is essential for lipopolysaccharide-induced, Toll-like receptor (TLR)-mediated macrophage activation. Interestingly, only agents that block FASN upstream of acetoacetyl-CoA synthesis, including the well-characterized FASN inhibitor C75, inhibited TLR4 signaling, while those acting downstream had no effect. We found that acetoacetyl-CoA could overcome C75's inhibitory effect, whereas other FASN metabolites, including palmitate, did not prevent C75-mediated inhibition. This suggested an unexpected role for acetoacetyl-CoA in inflammation that is independent of its role in palmitate synthesis. Our evidence further suggested that acetoacetyl-CoA arising from FASN activity promotes cholesterol production, indicating a surprising link between fatty acid synthesis and cholesterol synthesis. We further demonstrate that this process is required for TLR4 to enter lipid rafts and facilitate TLR4 signaling. In conclusion, we have uncovered an unexpected link between FASN and cholesterol synthesis that appears to be required for TLR signal transduction and proinflammatory macrophage activation
Analysis of CpG methylation sites and CGI among human papillomavirus DNA genomes
<p>Abstract</p> <p>Background</p> <p>The Human Papillomavirus (HPV) genome is divided into early and late coding sequences, including 8 open reading frames (ORFs) and a regulatory region (LCR). Viral gene expression may be regulated through epigenetic mechanisms, including cytosine methylation at CpG dinucleotides. We have analyzed the distribution of CpG sites and CpG islands/clusters (CGI) among 92 different HPV genomes grouped in function of their preferential tropism: cutaneous or mucosal. We calculated the proportion of CpG sites (PCS) for each ORF and calculated the expected CpG values for each viral type.</p> <p>Results</p> <p>CpGs are underrepresented in viral genomes. We found a positive correlation between CpG observed and expected values, with mucosal high-risk (HR) virus types showing the smallest O/E ratios. The ranges of the PCS were similar for most genomic regions except <it>E4</it>, where the majority of CpGs are found within islands/clusters. At least one CGI belongs to each <it>E2/E4 </it>region. We found positive correlations between PCS for each viral ORF when compared with the others, except for the LCR against four ORFs and <it>E6 </it>against three other ORFs. The distribution of CpG islands/clusters among HPV groups is heterogeneous and mucosal HR-HPV types exhibit both lower number and shorter island sizes compared to cutaneous and mucosal Low-risk (LR) HPVs (all of them significantly different).</p> <p>Conclusions</p> <p>There is a difference between viral and cellular CpG underrepresentation. There are significant correlations between complete genome PCS and a lack of correlations between several genomic region pairs, especially those involving LCR and <it>E6</it>. <it>L2 </it>and <it>L1 </it>ORF behavior is opposite to that of oncogenes <it>E6 </it>and <it>E7</it>. The first pair possesses relatively low numbers of CpG sites clustered in CGIs while the oncogenes possess a relatively high number of CpG sites not associated to CGIs. In all HPVs, <it>E2/E4 </it>is the only region with at least one CGI and shows a higher content of CpG sites in every HPV type with an identified <it>E4</it>. The mucosal HR-HPVs show either the shortest CGI size, followed by the mucosal LR-HPVs and lastly by the cutaneous viral subgroup, and a trend to the lowest CGI number, followed by the cutaneous viral subgroup and lastly by the mucosal LR-HPVs.</p
Serological screening and toxoplasmosis exposure factors among pregnant women in South of Brazil
Vocabulario de la sociedad civil, la ruralidad y los movimientos sociales en América Latina
El Vocabulario de la Sociedad Civil, la Ruralidad y los
Movimientos Sociales en América Latina tiene como
objetivo desarrollar vocablos relacionados con temas
de gran trascendencia para la vida colectiva de la
población Latinoamericana; pretende introducir a
estudiantes, personas del ámbito académico y activistas
en la comprensión de estas categorías de análisis.
A través de la mirada de 70 especialistas que
participaron en este vocabulario, es posible comprender
muchos de los términos que se utilizan dentro de
la investigación social y áreas relacionadas con las
ciencias políticas, ambientales y rurales, a partir de
una mayor explicación y detalle. Es por ello que se
inserta este trabajo desde una mirada colectiva y
amplia de los conceptos que se exponen.
En este libro podrá encontrar las ideas de varios autores
y autoras de distintas universidades, con una visión
multi, inter y transdisciplinaria. El esfuerzo que se
realizó para conjuntar varios términos y analizar su
compleja red de interpretaciones, permitirá que este
manuscrito pueda ser consultado por estudiantes,
personas del ámbito científico-académico, y ciudadanía;
porque contiene el estado del arte, la historia del
paulatino avance de múltiples conceptos y su vigencia
en el contexto actual
Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.
BACKGROUND: Remote ischaemic conditioning with transient ischaemia and reperfusion applied to the arm has been shown to reduce myocardial infarct size in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). We investigated whether remote ischaemic conditioning could reduce the incidence of cardiac death and hospitalisation for heart failure at 12 months. METHODS: We did an international investigator-initiated, prospective, single-blind, randomised controlled trial (CONDI-2/ERIC-PPCI) at 33 centres across the UK, Denmark, Spain, and Serbia. Patients (age >18 years) with suspected STEMI and who were eligible for PPCI were randomly allocated (1:1, stratified by centre with a permuted block method) to receive standard treatment (including a sham simulated remote ischaemic conditioning intervention at UK sites only) or remote ischaemic conditioning treatment (intermittent ischaemia and reperfusion applied to the arm through four cycles of 5-min inflation and 5-min deflation of an automated cuff device) before PPCI. Investigators responsible for data collection and outcome assessment were masked to treatment allocation. The primary combined endpoint was cardiac death or hospitalisation for heart failure at 12 months in the intention-to-treat population. This trial is registered with ClinicalTrials.gov (NCT02342522) and is completed. FINDINGS: Between Nov 6, 2013, and March 31, 2018, 5401 patients were randomly allocated to either the control group (n=2701) or the remote ischaemic conditioning group (n=2700). After exclusion of patients upon hospital arrival or loss to follow-up, 2569 patients in the control group and 2546 in the intervention group were included in the intention-to-treat analysis. At 12 months post-PPCI, the Kaplan-Meier-estimated frequencies of cardiac death or hospitalisation for heart failure (the primary endpoint) were 220 (8·6%) patients in the control group and 239 (9·4%) in the remote ischaemic conditioning group (hazard ratio 1·10 [95% CI 0·91-1·32], p=0·32 for intervention versus control). No important unexpected adverse events or side effects of remote ischaemic conditioning were observed. INTERPRETATION: Remote ischaemic conditioning does not improve clinical outcomes (cardiac death or hospitalisation for heart failure) at 12 months in patients with STEMI undergoing PPCI. FUNDING: British Heart Foundation, University College London Hospitals/University College London Biomedical Research Centre, Danish Innovation Foundation, Novo Nordisk Foundation, TrygFonden
Recommended from our members
Malonylation of GAPDH is an inflammatory signal in macrophages.
Macrophages undergo metabolic changes during activation that are coupled to functional responses. The gram negative bacterial product lipopolysaccharide (LPS) is especially potent at driving metabolic reprogramming, enhancing glycolysis and altering the Krebs cycle. Here we describe a role for the citrate-derived metabolite malonyl-CoA in the effect of LPS in macrophages. Malonylation of a wide variety of proteins occurs in response to LPS. We focused on one of these, glyceraldehyde-3-phosphate dehydrogenase (GAPDH). In resting macrophages, GAPDH binds to and suppresses translation of several inflammatory mRNAs, including that encoding TNFα. Upon LPS stimulation, GAPDH undergoes malonylation on lysine 213, leading to its dissociation from TNFα mRNA, promoting translation. We therefore identify for the first time malonylation as a signal, regulating GAPDH mRNA binding to promote inflammation
Frontal fibrosing alopecia: A multicenter review of 355 patients
Background: To our knowledge, there are no large multicenter studies concerning frontal fibrosing
alopecia (FFA) that could give clues about its pathogenesis and best treatment.
Objective: We sought to describe the epidemiology, comorbidities, clinical presentation, diagnostic
findings, and therapeutic choices in a large series of patients with FFA.
Methods: This retrospective multicenter study included patients given the diagnosis of FFA. Clinical
severity was classified based on the recession of the frontotemporal hairline.
Results: In all, 355 patients (343 women [49 premenopausal] and 12 men) with a mean age of 61 years (range
23-86) were included. Early menopause was detected in 49 patients (14%), whereas 46 (13%) had undergone
hysterectomy. Severe FFA was observed in 131 patients (37%). Independent factors associated with severe
FFA after multivariate analysis were: eyelash loss, facial papules, and body hair involvement. Eyebrow loss as
the initial clinical presentation was associated with mild forms. Antiandrogens such as finasteride and
dutasteride were used in 111 patients (31%), with improvement in 52 (47%) and stabilization in 59 (53%).
Limitations: The retrospective design is a limitation.
Conclusions: Eyelash loss, facial papules, and body hair involvement were associated with severe FFA.
Antiandrogens were the most useful treatment. ( J Am Acad Dermatol 2014;70:670-8.